Long-term improvement in patients with severe Parkinson's disease after implantation of fetal ventral mesencephalic tissue in a cavity of the caudate nucleus: 5-year follow up in 10 patients
- 1 June 1997
- journal article
- research article
- Published by Journal of Neurosurgery Publishing Group (JNSPG) in Journal of Neurosurgery
- Vol. 86 (6) , 931-942
- https://doi.org/10.3171/jns.1997.86.6.0931
Abstract
Different groups worldwide have observed in recent years that stereotactic implantation of fetal tissue can ameliorate the clinical symptoms of Parkinson's disease. The authors therefore investigated whether implantation of fetal ventral mesencephalic (FVM) tissue via open surgery is also capable of producing an improvement and whether this improvement is transient or long lasting. The authors report their findings in a 5-year follow-up study in 10 patients with Hoehn and Yahr Grade N or V Parkinson's disease in whom a single FVM graft was implanted in a cavity created in the right caudate nucleus. The results indicate that the implants improved motor function and that clinical recovery persisted in seven of the 10 patients 5 years after implantation. Amelioration was observed in both the on and off phases and was accompanied by a 64% reduction in the levodopa dose and withdrawal of the dopamine agonist. The on phase was prolonged from 39% of the waking day to 72%, with reduced intensity and duration of dyskinesias. All symptoms that were analyzed showed improvement, although they differed in intensity and time of onset. The course of improvement seemed to be stepwise, with significant improvement between 5 and 7 months postimplantation following by two waves of process peaking in Months 15 and 36. Withdrawal of cyclosporine in three patients after more than 2 years of administration produced a decline in the patients' clinical conditions. In conclusion, the results indicate that open surgery implantation of FVM tissue in the caudate nucleus improves the clinical condition of parkinsonian patients and that this improvement can persist for at least 5 years. In comparison with two earlier series reported by the authors, which involved implants of perfused adrenal medulla and coimplantation of adrenal medulla and peripheral nerve, the course and pattern of improvement in these implant recipients suggests that their recovery can be attributed to more than one factor.Keywords
This publication has 48 references indexed in Scilit:
- Bilateral motor improvement and alteration of L-dopa effect in two patients with Parkinson's disease following intrastriatal transplantation of foetal ventral mesencephalonBrain, 1994
- Cerebral Transplantation for Parkinson's Disease: Current Progress and Future ProspectsMayo Clinic Proceedings, 1993
- Co-transplantation of peripheral nerve and adrenal medulla in Parkinson's diseaseThe Lancet, 1992
- Glucocorticoids and the Development of Neuronal Function: Effects of Prenatal Dexamethasone Exposure on Central Noradrenergic ActivityNeonatology, 1992
- Long-term evaluation of hemiparkinsonian monkeys after adrenal autografting or cavitation aloneJournal of Neurosurgery, 1990
- The effect of fetal mesencephalon implants on primate MPTP-induced parkinsonismJournal of Neurosurgery, 1990
- Selective flow cytometric sorting of viable dopamine neuronsBrain Research, 1989
- Open Microsurgical Autograft of Adrenal Medulla to the Right Caudate Nucleus in Two Patients with Intractable Parkinson's DiseaseNew England Journal of Medicine, 1987
- FETAL NEURONAL GRAFTS IN MONKEYS GIVEN METHYLPHENYLTETRAHYDROPYRIDINEThe Lancet, 1986